|
1
|
Mohammadzadeh V, Rahiman N, Cabral H, Quader S, Zirak MR, Taghavizadeh Yazdi ME, Jaafari MR, Alavizadeh SH. Poly-γ-glutamic acid nanoparticles as adjuvant and antigen carrier system for cancer vaccination. J Control Release 2023; 362:278-296. [PMID: 37640110 DOI: 10.1016/j.jconrel.2023.08.049] [Citation(s) in RCA: 10] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2023] [Revised: 08/20/2023] [Accepted: 08/23/2023] [Indexed: 08/31/2023]
Abstract
Vaccination is an innovative strategy for cancer treatment by leveraging various components of the patients' immunity to boost an anti-tumor immune response. Rationally designed nanoparticles are well suited to maximize cancer vaccination by the inclusion of immune stimulatory adjuvants. Also, nanoparticles might control the pharmacokinetics and destination of the immune potentiating compounds. Poly-γ-glutamic acid (γ-PGA) based nanoparticles (NPs), which have a natural origin, can be easily taken up by dendritic cells (DCs), which leads to the secretion of cytokines which ameliorates the stimulation capacity of T cells. The intrinsic adjuvant properties and antigen carrier properties of γ-PGA NPs have been the focus of recent investigations as they can modulate the tumor microenvironment, can contribute to systemic anti-tumor immunity and subsequently inhibit tumor growth. This review provides a comprehensive overview on the potential of γ-PGA NPs as antigen carriers and/or adjuvants for anti-cancer vaccination.
Collapse
Affiliation(s)
- Vahideh Mohammadzadeh
- Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Niloufar Rahiman
- Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Horacio Cabral
- Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo 113-0033, Japan
| | - Sabina Quader
- Innovation Center of NanoMedicine (iCONM), Kawasaki Institute of Industrial Promotion, Kawasaki 210-0821, Japan
| | - Mohammad Reza Zirak
- Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
| | | | - Mahmoud Reza Jaafari
- Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran; Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Seyedeh Hoda Alavizadeh
- Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
| |
Collapse
|
|
2
|
Chetprayoon P, Matsusaki M, Yokoyama U, Tejima T, Ishikawa Y, Akashi M. Use of Three-Dimensional Arterial Models To Predict the In Vivo Behavior of Nanoparticles for Drug Delivery. Angew Chem Int Ed Engl 2016. [DOI: 10.1002/ange.201509752] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Paninee Chetprayoon
- Department of Applied Chemistry; Graduate School of Engineering; Osaka University; Yamadaoka, Suita Osaka 565-0871 Japan
| | - Michiya Matsusaki
- Department of Applied Chemistry; Graduate School of Engineering; Osaka University; Yamadaoka, Suita Osaka 565-0871 Japan
| | - Utako Yokoyama
- Cardiovascular Research Institute; Yokohama City University; Graduate School of Medicine; 3-9 Fukuura, Kanazawa-ku Yokohama, Kanagawa 236-0004 Japan
| | - Takanori Tejima
- Cardiovascular Research Institute; Yokohama City University; Graduate School of Medicine; 3-9 Fukuura, Kanazawa-ku Yokohama, Kanagawa 236-0004 Japan
| | - Yoshihiro Ishikawa
- Cardiovascular Research Institute; Yokohama City University; Graduate School of Medicine; 3-9 Fukuura, Kanazawa-ku Yokohama, Kanagawa 236-0004 Japan
| | - Mitsuru Akashi
- Department of Applied Chemistry; Graduate School of Engineering; Osaka University; Yamadaoka, Suita Osaka 565-0871 Japan
| |
Collapse
|
|
3
|
Chetprayoon P, Matsusaki M, Yokoyama U, Tejima T, Ishikawa Y, Akashi M. Use of Three-Dimensional Arterial Models To Predict the In Vivo Behavior of Nanoparticles for Drug Delivery. Angew Chem Int Ed Engl 2016; 55:4461-6. [DOI: 10.1002/anie.201509752] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2015] [Revised: 02/02/2016] [Indexed: 11/06/2022]
Affiliation(s)
- Paninee Chetprayoon
- Department of Applied Chemistry; Graduate School of Engineering; Osaka University; Yamadaoka, Suita Osaka 565-0871 Japan
| | - Michiya Matsusaki
- Department of Applied Chemistry; Graduate School of Engineering; Osaka University; Yamadaoka, Suita Osaka 565-0871 Japan
| | - Utako Yokoyama
- Cardiovascular Research Institute; Yokohama City University; Graduate School of Medicine; 3-9 Fukuura, Kanazawa-ku Yokohama, Kanagawa 236-0004 Japan
| | - Takanori Tejima
- Cardiovascular Research Institute; Yokohama City University; Graduate School of Medicine; 3-9 Fukuura, Kanazawa-ku Yokohama, Kanagawa 236-0004 Japan
| | - Yoshihiro Ishikawa
- Cardiovascular Research Institute; Yokohama City University; Graduate School of Medicine; 3-9 Fukuura, Kanazawa-ku Yokohama, Kanagawa 236-0004 Japan
| | - Mitsuru Akashi
- Department of Applied Chemistry; Graduate School of Engineering; Osaka University; Yamadaoka, Suita Osaka 565-0871 Japan
| |
Collapse
|
|
4
|
Ikuta Y, Koseki Y, Onodera T, Oikawa H, Kasai H. The effect of molecular structure on the anticancer drug release rate from prodrug nanoparticles. Chem Commun (Camb) 2015; 51:12835-8. [DOI: 10.1039/c5cc04164c] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
The controlled release of an anticancer agent from drug nanoparticles could be successfully achieved by optimizing the chemical structure of dimeric compounds as prodrug.
Collapse
Affiliation(s)
- Yoshikazu Ikuta
- Institute of Multidisciplinary Research for Advanced Materials
- Tohoku University
- Sendai
- Japan
| | - Yoshitaka Koseki
- Institute of Multidisciplinary Research for Advanced Materials
- Tohoku University
- Sendai
- Japan
| | - Tsunenobu Onodera
- Institute of Multidisciplinary Research for Advanced Materials
- Tohoku University
- Sendai
- Japan
| | - Hidetoshi Oikawa
- Institute of Multidisciplinary Research for Advanced Materials
- Tohoku University
- Sendai
- Japan
| | - Hitoshi Kasai
- Institute of Multidisciplinary Research for Advanced Materials
- Tohoku University
- Sendai
- Japan
| |
Collapse
|